Role of CaMKII in Ang-II-dependent small artery remodeling

Area of Science:

• Cardiovascular Biology
• Vascular Physiology
• Molecular Medicine

Background:

• Angiotensin-II (Ang-II) is a key mediator of vascular remodeling.
• Calcium-Calmodulin-Dependent Kinase II (CaMKII) is activated by Ang-II and influences smooth muscle cell signaling in vitro.
• The in vivo role of CaMKII in Ang-II-dependent vascular remodeling remains unclear.

Purpose of the Study:

• To investigate the role of CaMKII in Ang-II-mediated vascular remodeling and function in vivo.
• To determine the impact of selective smooth muscle cell CaMKII inhibition on vascular responses to Ang-II.

Main Methods:

• Utilized a transgenic mouse model with CaMKII inhibition specifically in smooth muscle cells.
• Administered chronic Ang-II treatment to induce vascular remodeling.
• Assessed vascular remodeling and agonist-dependent vasoconstriction in mesenteric arteries.

Main Results:

• CaMKII inhibition exacerbated vascular remodeling in response to chronic Ang-II.
• Inhibition of CaMKII led to increased agonist-dependent vasoconstriction in mesenteric arteries.
• Elevated mRNA and protein expression of smooth muscle structural proteins were observed with CaMKII inhibition.
• CaMKII was found to reduce serum response factor-dependent transcriptional activity.

Conclusions:

• CaMKII acts as a critical regulator of smooth muscle cell function in the context of Ang-II-induced hypertension.
• CaMKII inhibition impairs normal vascular adaptation to Ang-II, leading to adverse remodeling and heightened vasoconstriction.
• These findings highlight CaMKII as a potential therapeutic target for managing hypertensive vascular disease.